首页/数据集/Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men

Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men

NCATS Open Data2023-07-21 更新2026-08-08 收录

疫苗临床试验

流感疫苗免疫原性

数据链接：

https://doi.org/10.1038/s41467-023-39766-x 数据链接链接失效反馈

官方服务：

资源简介：

Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men

应用场景：

创建时间：

2023-07-08

流感疫苗免疫原性

年龄相关免疫应答差异

Seasonal influenza vaccines are available in multiple formulations including egg-based inactivated standard-dose, cell-based inactivated, recombinant, and live-attenuated. However, vaccine effectivene

NIAID Data Ecosystem100

ATN 064 Burk HPV DNA Dataset in Immunogenicity, Safety, Tolerability, and Behavioral Consequences of an HPV-6, -11, -16, -18 Vaccine in HIV-Infected Young Women

疫苗临床试验

HIV感染者免疫干预

Burk Lab HPV DNA data Study Description A Phase II, open-label, multi-center study that evaluated the immunogenicity, safety, tolerability, and behavioral impact of an HPV-6, -11, -16, -18 vaccine in

NIAID Data Ecosystem40

Dataset from Safety and Immunogenicity Study of GSK Biologicals' Candidate Tuberculosis Vaccine (692342) When Administered to Healthy Infants

疫苗临床试验

结核病预防

This purpose of the study is to assess the safety and immunogenicity of a GSK Biologicals' candidate tuberculosis vaccine (692342) when administered concomitantly with or after the Expanded Programme

NIAID Data Ecosystem20

Hemagglutination-Inhibition Titer

流感疫苗免疫原性

血凝抑制试验抗体滴度

aDose based upon HA contentbInfluenza viruses used in the HAI assay against sera collected at week 5.cHAI GMT plus or minus SEM.dVLP vs. rHA comparing same dose, t-test, *p

Figshare2015-12-02 更新70

Characteristics of HVTN 502 and 503 trial participants.

疫苗临床试验

免疫基因型分析

Data shown are median values (interquartile range) unless otherwise indicated. * At time of sampling § HLA-B*27, B51, B*5701/03, B*5801 and B*8101 Characteristics of HVTN 502 and 503 trial participant

NIAID Data Ecosystem20

Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men

资源简介：

相关数据集